HF
CGEM icon

HRT Financial’s Cullinan Oncology CGEM Stock Holding History

HRT Financial’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,586
Closed -$548K – 4317
2026
Q1 		$548K Sell
38,586
-45,481
-54% -$584K ﹤0.01% 2447
2025
Q4 		$870K Buy
84,067
+41,958
+100% +$378K ﹤0.01% 1804
2025
Q3 		$249K Buy
+42,109
New +$308K ﹤0.01% 2292
2025
Q2 		– Sell
-20,850
Closed -$157K – 2720
2025
Q1 		$157K Buy
+20,850
New +$200K ﹤0.01% 2074
2023
Q3 		– Sell
-28,495
Closed -$306K – 2459
2023
Q2 		$306K Buy
+28,495
New +$303K ﹤0.01% 1614
2022
Q2 		– Sell
-14,180
Closed -$148K – 3009
2022
Q1 		$148K Buy
+14,180
New +$192K ﹤0.01% 2562

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

HRT Financial's CGEM Position: Q2 2026 in Review

HRT Financial sold out of Cullinan Oncology (CGEM) in Q2 2026, closing a stake of 38,586 shares — an estimated $548K sold.

HRT Financial first reported a position in CGEM in Q1 2022 and held it in 6 quarters. The position peaked at $870K in Q4 2025. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • HRT Financial reported no remaining Cullinan Oncology position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 38,586 Cullinan Oncology shares in Q2 2026, an estimated $548K.
  • HRT Financial first reported a position in Cullinan Oncology in Q1 2022 and held it in 6 quarters.
  • HRT Financial's Cullinan Oncology position peaked at $870K in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.